Literature DB >> 15459138

Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps.

P-R Burgel1, L O Cardell, I F Ueki, J A Nadel.   

Abstract

Increased mucin expression is a feature of nasal polyposis. Corticosteroids reduce polyp size and symptoms, but their effect on mucin production remains unknown. In this study, the effects of intranasal corticosteroids on MUC5AC mucin expression, nasal resistance, eosinophil and neutrophil infiltration, epidermal growth factor receptor (EGFR), interleukin (IL)-8, and tumour necrosis factor (TNF)-alpha expression was assessed in nasal polyps. In nine subjects, one nasal polyp was removed surgically before treatment and another was removed after 8 weeks of intranasal fluticasone (400 microg.day(-1)). Tissues were processed for in situ hybridisation and immunohistochemical staining. Described effects of fluticasone on nasal polyps (reduction in nasal resistance and in eosinophil infiltration) were evaluated. Morphometric analysis was performed to assess the effect of fluticasone on epithelial-, MUC5AC-, EGFR- and IL-8-stained areas, TNF-alpha-stained cells, and neutrophil numbers. Treatment with fluticasone decreased nasal resistance and intra-epithelial eosinophils. The MUC5AC-stained area in the epithelium was unchanged by treatment; MUC5AC mRNA expression was unaffected by treatment. EGFR-stained area, intra-epithelial neutrophil numbers, IL-8 and TNF-alpha expression were also unchanged by therapy. Intranasal fluticasone was effective in decreasing nasal airflow resistance and intra-epithelial eosinophils but had no effect on mucin or epidermal growth factor receptor expression or on neutrophil recruitment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459138     DOI: 10.1183/09031936.04.00014404

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

Review 1.  Management of the upper airway in cystic fibrosis.

Authors:  Elisa A Illing; Bradford A Woodworth
Journal:  Curr Opin Pulm Med       Date:  2014-11       Impact factor: 3.155

Review 2.  Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

Authors:  Muzafar A Macha; Shiv Ram Krishn; Rahat Jahan; Kasturi Banerjee; Surinder K Batra; Maneesh Jain
Journal:  Cancer Treat Rev       Date:  2015-01-14       Impact factor: 12.111

3.  A morphometric study of mucins and small airway plugging in cystic fibrosis.

Authors:  Pierre-Régis Burgel; David Montani; Claire Danel; Daniel J Dusser; Jay A Nadel
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

Review 4.  Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.

Authors:  Helen Beer; Kevin W Southern; Andrew C Swift
Journal:  Cochrane Database Syst Rev       Date:  2015-06-22

Review 5.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

6.  Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis.

Authors:  Mohammad Hossein Baradaranfar; Zeynab Sadat Ahmadi; Mohammad Hossein Dadgarnia; Mohammad Hossein Bemanian; Saeid Atighechi; Ghasem Karimi; Abolhasan Halvani; Nasim Behniafard; Amin Baradaranfar; Tohid Emami Meybodi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-23       Impact factor: 2.503

Review 7.  Targeting mucus hypersecretion: new therapeutic opportunities for COPD?

Authors:  Clémence Martin; Justine Frija-Masson; Pierre-Régis Burgel
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

8.  Expression and Regulation of Transcription Factor FoxA2 in Chronic Rhinosinusitis With and Without Nasal Polyps.

Authors:  Qing Luo; Jia Zhang; Hongtian Wang; Fenghong Chen; Xi Luo; Beiping Miao; Xingmei Wu; Renqiang Ma; Xiangqian Luo; Geng Xu; Jianbo Shi; Huabin Li
Journal:  Allergy Asthma Immunol Res       Date:  2015-05-22       Impact factor: 5.764

9.  A review of nasal polyposis.

Authors:  Jonathan Ray Newton; Kim Wong Ah-See
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

10.  Interleukin-17A promotes MUC5AC expression and goblet cell hyperplasia in nasal polyps via the Act1-mediated pathway.

Authors:  Wentong Xia; Jing Bai; Xingmei Wu; Yi Wei; Shaoyan Feng; Lei Li; Jia Zhang; Guanxia Xiong; Yunping Fan; Jianbo Shi; Huabin Li
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.